Clinical Trial Update: A Phase I Clinical Trial to Evaluate CU-10101 Unguent [Phase 1]

View source ↗

Summary

This document reports a Phase I clinical trial of CU-10101 Unguent for atopic dermatitis, with enrollment by invitation currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• CU-10101 Unguent

Snippet

Sponsor: Cutia Therapeutics（Wuxi）Co.,Ltd | Conditions: Atopic Dermatitis | Phase 1 | Status: ENROLLING_BY_INVITATION